- Report
- June 2025
- 269 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- August 2025
- 147 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- December 2024
- 150 Pages
Global
From €5250EUR$5,950USD£4,541GBP
- Report
- August 2025
- 186 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 188 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- February 2025
- 200 Pages
Global
From €3962EUR$4,490USD£3,427GBP
- Report
- August 2025
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
- Report
- November 2024
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- August 2025
- 187 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- September 2025
- 475 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 118 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 372 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- January 2025
- 185 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- September 2025
- 377 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2025
- 373 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- February 2025
- 182 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- January 2024
- 483 Pages
Global
From €6309EUR$7,150USD£5,457GBP
- Report
- January 2024
- 150 Pages
Global
From €3397EUR$3,850USD£2,938GBP
€4280EUR$4,850USD£3,701GBP
- Report
- August 2024
- 145 Pages
Global
From €2646EUR$2,999USD£2,289GBP

The Drug Metabolism market within the context of Biotechnology is a rapidly growing sector, with a focus on the development of new drugs and treatments. It involves the study of how drugs are broken down and metabolized in the body, and how this affects their efficacy and safety. This market is driven by the need for more effective and safer drugs, as well as the increasing demand for personalized medicine. Companies in this market are developing new technologies to improve drug metabolism, such as artificial intelligence and machine learning. They are also exploring new ways to identify and target drug metabolism pathways, as well as developing new drug delivery systems.
Some companies in the Drug Metabolism market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more